Susquehanna International Group, LLP Annovis Bio, Inc. Put Options Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$5.27 - $15.46 $1.06 Million - $3.12 Million
-201,700 Reduced 60.7%
130,600 $1.05 Million
Q2 2024

Aug 15, 2024
BUY
$4.82 - $18.01 $960,626 - $3.59 Million
199,300 Added 149.85%
332,300 $1.91 Million
Q1 2024

May 07, 2024
BUY
$8.47 - $18.93 $1.13 Million - $2.52 Million
133,000 New
133,000 $1.58 Million

Others Institutions Holding ANVS

# of Institutions
45
Shares Held
1.16M
Call Options Held
229K
Put Options Held
934K
View Full List

About Annovis Bio, Inc.

ANVS Quotes by TradingView
  • Ticker ANVS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,163,920
  • Market Cap $58M
  • Description
  • Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease ...
More about ANVS
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email